Stem Cell Derivation
Human embryonic stem cells have various applications in basic and medical research. They are expected to become a very valuable tool in the fight against currently incurable devastating diseases. Very early on Genea recognised this potential and thus re-invests about 10% of annual revenues into Stem Cell Research. Genea are now on the forefront of Australian Stem Cell Research and has under Research involving human embryos Act 2002 derived the first human embryonic stem cell line in Australia.
Genea's Stem Cell division continues its research and development program in order to make the benefits of stem cell technology available to both the health care industry and national and international academic research institutions.